Elevated amortization impacting PAT
Amortization of intangibles from acquisitions increased to ₹396 million in Q3, expected to remain elevated for three more quarters, pressuring reported PAT.
INDGN / Q3-FY26 / risks
Keep the risk register visible.
Indegene · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Margin pressure from upfront investments
Planned investments of 150bps in go-to-market and GenAI capabilities, plus upfront costs on large deals, may delay margin recovery.
Currency volatility and hedging effectiveness
Sharp currency moves could impact financials; management reviews hedging policy periodically but does not guarantee full protection.
Integration risks from Bioarm acquisition
While integration is on track, any disruption in client engagements or employee retention could affect expected synergies.